These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 868807)

  • 1. False-negative test for fibrinogen--fibrin degradation products.
    Kickler T; Bell WR
    Am J Clin Pathol; 1977 Jul; 68(1):78-80. PubMed ID: 868807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of a direct latex-agglutination technic with the tanned red cell hemagglutination inhibition immunoassay (TRCHII) for semiquantitation of fibrinogen/fibrin degradation products.
    Wilson JE; Thornton RD
    Am J Clin Pathol; 1976 Apr; 65(4):528-32. PubMed ID: 1266814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of hemagglutination inhibition, staphylococcal clumping, and latex agglutination tests for canine fibrinolytic degradation products.
    Chen JP; Williams TK; Legendre AM
    Am J Vet Res; 1981 Dec; 42(12):2049-52. PubMed ID: 7340573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative sensitivity of two hemagglutination inhibition immunoassays for fibrinolytic degradation products in human serum.
    Chi DS; Chen JP
    Thromb Haemost; 1976 Apr; 35(2):423-36. PubMed ID: 823661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New enzyme immunoassay of fibrin-fibrinogen degradation products in plasma using a monoclonal antibody.
    Koopman J; Haverkate F; Koppert P; Nieuwenhuizen W; Brommer EJ; Van der Werf WG
    J Lab Clin Med; 1987 Jan; 109(1):75-84. PubMed ID: 3540164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical evaluation of a test for plasma fibrin/fibrinogen degradation products (FDP) based on monoclonal anti-FDP antibody technology: an application for the scoring system of the disseminated intravascular coagulation (DIC) diagnostic criteria].
    Ito K; Wada H; Abe Y; Tomatsu H; Nishioka J; Nobori T
    Rinsho Byori; 2003 Apr; 51(4):295-9. PubMed ID: 12747249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibrinogen-fibrin degradation products: hemagglutination inhibition immunoassay in plasma.
    Chi DS; Chen JP
    Tex Rep Biol Med; 1975; 33(4):493-508. PubMed ID: 133472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ristocetin precipitation test: a new simple test for detection of fibrin monomer and fibrin degradation products.
    Watanabe K; Tullis JL
    Am J Clin Pathol; 1978 Oct; 70(4):691-6. PubMed ID: 707435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new anti-fibrinogen-coated latex particle agglutination test in the measurement of serum fibrin degradation products.
    Marder VJ; Cruz GO; Schumer BR
    Thromb Haemost; 1977 Apr; 37(2):183-91. PubMed ID: 577622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A proposed method for the laboratory diagnosis of disseminated intravascular coagulation in liver cirrhosis].
    Cristani A; Cioni G; Mussini C; Pentore R; Zagni G; Ventura E
    Recenti Prog Med; 1990 May; 81(5):322-4. PubMed ID: 2377810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between radioimmunoassay and other immunological techniques for the measurement of fibrinogen/fibrin degradation products in serum.
    Ratky SM; Martin MJ; Gordon YB; Baker LR; Chard T; Leslie J
    Br J Haematol; 1975 Jun; 30(2):145-9. PubMed ID: 1201206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of D dimer in patients with elevated fibrinogen degradation products in serum: further study in chronic myelogenous leukemia.
    Saito M; Asakura H; Jokaji H; Uotanzi C; Kumabashiri I; Yoshida T; Hashizume K; Matsuda T
    Acta Haematol; 1990; 84(3):149-55. PubMed ID: 2123066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of disseminated intravascular coagulation. Role of D-dimer.
    Carr JM; McKinney M; McDonagh J
    Am J Clin Pathol; 1989 Mar; 91(3):280-7. PubMed ID: 2646905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of fibrinogen degradation products (FDP) in serum of normal and tumor-bearing rats.
    Abe K; Fujimoto H; Endo E; Fukuoka Y; Khato J
    Tohoku J Exp Med; 1975 Dec; 117(4):343-50. PubMed ID: 174248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of various rapid methods of determining fibrinogen transformation products in the diagnosis of intravascular coagulation and fibrinolysis].
    Lychev VG; Momot AP; Cherkashin GV
    Ter Arkh; 1984; 56(6):106-9. PubMed ID: 6474366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent progress on analysis of blood coagulation factors and fibrinolytic agents; FDP D dimer analysis using NANOPIA FDP].
    Matsumoto T; Sakai Y; Maeda M; Takei F
    Rinsho Byori; 1989 Apr; Spec No 81():183-8. PubMed ID: 2754806
    [No Abstract]   [Full Text] [Related]  

  • 17. False negative results with latex-based test for fibrinogen degradation products.
    Copplestone A; Francis D; Chisholm M
    Lancet; 1983 Nov; 2(8359):1444. PubMed ID: 6138683
    [No Abstract]   [Full Text] [Related]  

  • 18. [FDP-D dimer and FDP-E fraction (FDP-E)].
    Amemiya N
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():608-10. PubMed ID: 15658402
    [No Abstract]   [Full Text] [Related]  

  • 19. [Standardization of FDP/D-dimer test].
    Fukutake K
    Rinsho Byori; 2011 Feb; Suppl 147():199-201. PubMed ID: 21761772
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fibrin/fibrinogen degradation products (FDP)].
    Kuroso K; Fujimaki M
    Nihon Rinsho; 1989 Dec; 48 Suppl():892-5. PubMed ID: 2622025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.